scholarly journals Hot Off the Press: SGEM #264—Hooked on A Feeling? Opioid Use and Misuse Three Months After Emergency Department Visit for Acute Pain

2019 ◽  
Vol 27 (3) ◽  
pp. 240-242
Author(s):  
Corey Heitz ◽  
Justin Morgenstern ◽  
Christopher Bond ◽  
William K. Milne
2019 ◽  
Vol 26 (8) ◽  
pp. 847-855 ◽  
Author(s):  
Raoul Daoust ◽  
Jean Paquet ◽  
Sophie Gosselin ◽  
Gilles Lavigne ◽  
Alexis Cournoyer ◽  
...  

2020 ◽  
Vol 75 (5) ◽  
pp. 578-586 ◽  
Author(s):  
Benjamin W. Friedman ◽  
Lorena Abril Ochoa ◽  
Farnia Naeem ◽  
Hector R. Perez ◽  
Joanna L. Starrels ◽  
...  

Author(s):  
Utsha G. Khatri ◽  
Elizabeth A. Samuels ◽  
Ruiying Xiong ◽  
Brandon D.L. Marshall ◽  
Jeanmarie Perrone ◽  
...  

Pain Medicine ◽  
2020 ◽  
Author(s):  
Danielle M McCarthy ◽  
Howard S Kim ◽  
Scott I Hur ◽  
Patrick M Lank ◽  
Christine Arroyo ◽  
...  

Abstract Objectives Recent guidelines advise limiting opioid prescriptions for acute pain to a three-day supply; however, scant literature quantifies opioid use patterns after an emergency department (ED) visit. We sought to describe opioid consumption patterns after an ED visit for acute pain. Design Descriptive study with data derived from a larger interventional study promoting safe opioid use after ED discharge. Setting Urban academic emergency department (>88,000 annual visits). Subjects Patients were eligible if age >17 years, not chronically using opioids, and newly prescribed hydrocodone-acetaminophen and were included in the analysis if they returned the completed 10-day medication diary. Methods Patient demographics and opioid consumption are reported. Opioid use is described in daily number of pills and daily morphine milligram equivalents (MME) both for the sample overall and by diagnosis. Results Two hundred sixty patients returned completed medication diaries (45 [17%] back pain, 52 [20%] renal colic, 54 [21%] fracture/dislocation, 40 [15%] musculoskeletal injury [nonfracture], and 69 [27%] “other”). The mean age (SD) was 45 (15) years, and 59% of the sample was female. A median of 12 pills were prescribed. Patients with renal colic used the least opioids (total pills: median [interquartile range {IQR}] = 3 [1–7]; total MME: median [IQR] = 20 [10–50]); patients with back pain used the most (total pills: median [IQR] = 12 [7–16]; total MME: median [IQR] = 65 [47.5–100]); 92.5% of patients had leftover pills. Conclusions In this sample, pill consumption varied by illness category; however, overall, patients were consuming low quantities of pills, and the majority had unused pills 10 days after their ED visit.


10.36469/9793 ◽  
2017 ◽  
Vol 5 (1) ◽  
pp. 1-15 ◽  
Author(s):  
Pamela P. Palmer ◽  
Judith A. Walker ◽  
Asad E. Patanwala ◽  
Carin A. Hagberg ◽  
John A. House

Background: Pain is a leading cause of admission to the emergency department (ED) and moderate-to-severe acute pain in medically supervised settings is often treated with intravenous (IV) opioids. With novel noninvasive analgesic products in development for this indication, it is important to assess the costs associated with IV administration of opioids. Materials and Methods: A retrospective observational study of data derived from the Premier database was conducted. All ED encounters of adult patients treated with IV opioids during a 2-year time period, who were charged for at least one IV opioid administration in the ED were included. Hospital reported costs were used to estimate the costs to administer IV opioids. Results: Over a 24 month-period, 7.3 million encounters, which included the administration of IV opioids took place in 614 US EDs. The mean cost per encounter of IV administration of an initial dose of the three most frequently prescribed opioids were: morphine $145, hydromorphone $146, and fentanyl $147. The main driver of the total costs is the cost of nursing time and equipment cost to set up and maintain an IV infusion ($140 ± 60). Adding a second dose of opioid, brings the average costs to $151-$154. If costs associated with the management of opioid-related adverse events and IV-related complications are also added, the total costs can amount to $269-$273. Of these 7.3 million encounters, 4.3 million (58%) did not lead to hospital admission of the patient and, therefore, the patient may have only required an IV catheter for opioid administration. Conclusions: IV opioid use in the ED is indicated for moderate-to-severe pain but is associated with significant costs. In subjects who are discharged from the ED and may not have required an IV for reasons other than opioid administration, rapid-onset analgesics for moderate-to-severe pain that do not require IV administration could lead to direct cost reductions and improved care.


2019 ◽  
Vol 74 (4) ◽  
pp. S100
Author(s):  
L.A. Ochoa ◽  
E. Irizarry ◽  
F. Naaem ◽  
B.W. Friedman

2019 ◽  
Vol 74 (2) ◽  
pp. 224-232 ◽  
Author(s):  
Raoul Daoust ◽  
Jean Paquet ◽  
Alexis Cournoyer ◽  
Éric Piette ◽  
Judy Morris ◽  
...  

Author(s):  
Raoul Daoust ◽  
Jean Paquet ◽  
Verilibe Huard ◽  
Jean-Marc Chauny ◽  
Gilles Lavigne ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document